Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience
about
An overview of quinoline as a privileged scaffold in cancer drug discovery.Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy.A network meta-analysis of short-term efficacy of different single-drug targeted therapies in the treatment of renal cell carcinoma.Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression.Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
P2860
Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cabozantinib in the treatment ...... trial evidence and experience
@ast
Cabozantinib in the treatment ...... trial evidence and experience
@en
Cabozantinib in the treatment ...... trial evidence and experience
@nl
type
label
Cabozantinib in the treatment ...... trial evidence and experience
@ast
Cabozantinib in the treatment ...... trial evidence and experience
@en
Cabozantinib in the treatment ...... trial evidence and experience
@nl
prefLabel
Cabozantinib in the treatment ...... trial evidence and experience
@ast
Cabozantinib in the treatment ...... trial evidence and experience
@en
Cabozantinib in the treatment ...... trial evidence and experience
@nl
P2860
P356
P1476
Cabozantinib in the treatment ...... trial evidence and experience
@en
P2093
D. Y. C. Heng
J. M. Ruiz-Morales
P2860
P304
P356
10.1177/1756287216663073
P407
P577
2016-12-01T00:00:00Z